NCT04388618

Brief Summary

COVID-19 has adversely affected the healthcare system across the world. The world was not prepared for global outbreak of infectious diseases. The rapid spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is enabling researchers worldwide to acquire a large amount of clinical data regarding coronavirus disease (COVID-19). The COVID-19 infection severely affects the respiratory system in the critical cases and results in mortalities. The affected people experience a dry cough, fever, breathing problems, diarrhea, muscle pain, and sore throat. Besides that, some of the evidence from Italy, South Korea, China, and Spain suggest that the COVID-19 cases also lose their senses of smell and taste resulting in alterations in those patients. The objective of this proposed study is to determine whether COVID-19 cases have Olfactory and gustatory dysfunctions as a hallmark indicator and can be used as diagnostic tools for the isolation of suspected people. Investigators are presenting a prospective proportional case-control study that is conducted to investigate the COVID-19 cases with anosmia and /or Ageusia in a university hospital in Riyadh, Saudi Arabia. The sample size of this case series would be 250 cases of suspected COVID-19 patients. The cases included in the study are analyzed prospectively to determine if the cases had a history of anosmia and /or Ageusia, and then tested for the alteration of these senses through a panel of standardized odors/taste strips. That is looked at statistically allowing us to confirm the proposed effectiveness of these tests as a diagnostic tool.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
250

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jun 2020

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 13, 2020

Completed
1 day until next milestone

First Posted

Study publicly available on registry

May 14, 2020

Completed
1 month until next milestone

Study Start

First participant enrolled

June 15, 2020

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2021

Completed
Last Updated

May 4, 2022

Status Verified

May 1, 2022

Enrollment Period

1.5 years

First QC Date

May 13, 2020

Last Update Submit

May 2, 2022

Conditions

Keywords

anosmiaageusiacovid19corona virus infection

Outcome Measures

Primary Outcomes (1)

  • correlation of anosmia and ageusia to covid19 positive patients

    to how extent alteration of smell and taste senses is related to covid19 status

    from 1/06/2020 to 31/12/2020

Secondary Outcomes (1)

  • objective assessment of severity of smell and taste senses alterations in covid19 patients

    from 1/06/2020 to 31/12/2020

Study Arms (2)

covid19 positive patients

participants who present with signs and symptoms suspected for covid19 and swabbed/tested positive

Other: NHANES smell and taste tests

covid19 negative patients

participants who present with signs and symptoms suspected for covid19 and swabbed/tested negative

Other: NHANES smell and taste tests

Interventions

participants will be asked to smell 8 cards of different odors and submit your choices in a given card, and so for 3 different taste tips (salty, bitter and neutral). participants will be asked to submit his choices in a given card as well. Then participants photograph those cards and send it via WhatsApp to a given number to be collected

covid19 negative patientscovid19 positive patients

Eligibility Criteria

Age12 Years - 65 Years
Sexall
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Upon identification of the patient in the triage area the research assistant will start the study by introducing the concept for the patient and then taking consent. The patient will go through the regular flow of patients in the ED and after being asked to do the swabs the research assistant will start the process of the study by testing the smell by the NHANES cards then directly assess the taste by the NHANES strips and documents the results on the cards

You may qualify if:

  • Suspected cases of COVID -19 fulfilling the case definition of Saudi CDC 2- Adult patients

You may not qualify if:

  • The cases of children under the age of 12 years
  • Known patients with Kallmann's syndrome, CHARGE syndrome, Indifference to pain syndrome, ciliopathy disorders.
  • Known patient with congenital anomalies, absent smell sense, and absent taste sense.
  • Pregnant and lactating ladies
  • Patients with trigeminal nerve disease
  • Blind and deaf patients
  • Malingering.
  • Adults aged more than 65 years old.
  • Allergy to quinine products

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Princess Nourah Bint Abdulrahman Univeristy

Riyadh, Central, 11552, Saudi Arabia

Location

prince Mohammed bin Abdulaziz Hospital

Riyadh, Central, Saudi Arabia

Location

MeSH Terms

Conditions

AnosmiaAgeusiaCOVID-19Coronavirus Infections

Condition Hierarchy (Ancestors)

Olfaction DisordersSensation DisordersNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and SymptomsTaste DisordersPneumonia, ViralPneumoniaRespiratory Tract InfectionsInfectionsVirus DiseasesCoronaviridae InfectionsNidovirales InfectionsRNA Virus InfectionsLung DiseasesRespiratory Tract Diseases

Study Officials

  • OSAMA KENTAB, M.D

    Princess Nourah Bint Abdulrahman University

    PRINCIPAL INVESTIGATOR
  • AHMAD AALIBRAHIM, M.D

    Princess Nourah Bint Abdulrahman University

    STUDY DIRECTOR
  • MARZOOQA ALENIZI, M.D

    Princess Nourah Bint Abdulrahman University

    STUDY CHAIR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
m.d, FAAP, FACEP , CLINICAL ASSOCIATE PROFESSOR OF EMERGENCY MEDICINE, SENIOR CONSULTANT PEDIATRIC EMERGENCY MEDICINE

Study Record Dates

First Submitted

May 13, 2020

First Posted

May 14, 2020

Study Start

June 15, 2020

Primary Completion

December 31, 2021

Study Completion

December 31, 2021

Last Updated

May 4, 2022

Record last verified: 2022-05

Locations